A key biological puzzle is to understand how a known environmental agent reacts with a genetic polymorphism in such a manner that some subjects of a given phenotype are more prone to develop a particular disorder. Bladder cancers are known to occur at a higher rate in subjects exposed to aromatic amines either in tobacco smoke or in their occupations.' It has been found in both human and rabbit populations that some carcinogenic aromatic amines (for example, amino-fluorene, benzidine, and 2-naphthyl-amine) are polymorphically acetylated by the same N-acetyl-transferase that is responsible for the polymorphic acetylation of a number of drugs.2 3 In this genetic polymorphism slow acetylation is an autosomal recessive phenotype.4 These considerations have led to the suggestion that the two human acetylator phenotypes may differ in their predisposition to develop neoplastic disorders believed to be caused by aromatic amines. This idea is based on an analogy with the now established fact that genetic constitution can predispose to drug toxicity.5 An obvious example to test the hypothesis is bladder cancer.
A key biological puzzle is to understand how a known environmental agent reacts with a genetic polymorphism in such a manner that some subjects of a given phenotype are more prone to develop a particular disorder. Bladder cancers are known to occur at a higher rate in subjects exposed to aromatic amines either in tobacco smoke or in their occupations. ' It has been found in both human and rabbit populations that some carcinogenic aromatic amines (for example, amino-fluorene, benzidine, and 2-naphthyl-amine) are polymorphically acetylated by the same N-acetyl-transferase that is responsible for the polymorphic acetylation of a number of drugs. 2 Heterogeneity is tested by X2N_1 = Wy2 -w =1-4824 (p>0-10). In studies of statistical associations of genetically determined phenotypes with disorders, the matter of selection is of importance. The Liverpool bladder cancer patients were people who had survived over a period and who lived in a defined area, so selection factors might have been introduced. It is possible that the survival factor might influence the results in other studies in table 2.
Another point of great importance is the nature of the control populations. Two separate sets of controls were studied by Lower et al. 6 Each separate study has its own control group and the sets of controls were non-random and collected in different ways, one set to accompany the urban Copenhagen D A P Evans, L C Eze, and E J Whibley patients and another to accompany the rural Lund patients. In each case the controls were "healthy hospital personnel and hospital patients". A series of geriatric patients without malignant disease constituted the controls of Woodhouse et al.7
The London-based controls of Cartwright et a18
were "healthy subjects from Guy's Hospital", and the Huddersfield controls were either non-bladder cancer urological patients or "patients undergoing cold surgery for various conditions". The six Liverpool control series which were pooled comprised variously healthy medical students, healthy hospital and university staff, and tuberculous patients. It may be speculated that the lack of heterogeneity of the association between the series ( 
